Cerebral blood flow and oxygenation in rat brain after soman exposure.

Toxicol Lett

Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada. Electronic address:

Published: January 2021

AI Article Synopsis

  • Nerve agents can cause serious neurological damage that current treatments don't fully address, highlighting the need for better neuroprotective therapies.
  • Recent research indicates that seizures induced by nerve agents may lead to vascular changes that can mitigate some of the neurological damage.
  • A study measuring oxygen consumption and blood flow in rats after soman exposure showed decreased cerebral blood flow, suggesting impaired metabolism and potential cellular damage following exposure.

Article Abstract

Nerve agent exposure can cause debilitating neurological damage even with treatment. Currently accepted treatments involve attenuating the cholinergic crisis and seizure onset but do not focus directly on neuroprotection. Hence, there is a need for improved treatments to reduce neurological deficits. It is important to understand the pathophysiology of nerve agent mediated injury in order to identify effective treatment targets. Nerve agent-induced seizures are believed to be the main contributor to the neuropathology. Recently seizures have been shown to cause vascular changes that may actually attenuate neurological damage. This study evaluated the effect of soman-induced convulsive seizures on the relationship between CNS oxygen consumption and supply. To simultaneously assess changes in oxygenation and perfusion, rats were implanted with permanently fixed fiber-optic tissue oxygen sensing probes in the motor cortex and imaged with continuous arterial spin labelling MRI to measure cerebral blood flow. Baseline tissue oxygen tension (ptO) and cerebral blood flow (CBF) were measured in isoflurane anaesthetized rats at least one day prior to soman or saline exposure. Rats were pretreated with HI-6 dimethansulfonate and atropine methyl nitrate (125 mg/kg and 20 mg/kg; intraperitoneal) followed by a convulsive dose of soman (90 μg/kg; subcutaneous) or equal volume of saline. Three additional treatments of HI-6/AMN were administered to improve survival. At 1.5 -hs after exposure, ptO and cerebral blood flow measurements were conducted. There was a significant decrease in CBF 1.5 -hs following soman exposure but no change in ptO was found. When we correlated ptO and CBF, for a given ptO, there was lower CBF following soman exposure. This may indicate metabolism is inhibited, possibly because of mitochondrial impairment, therefore reducing oxygen demand. These data show hypoperfusion in brain following soman exposure which would be expected to contribute to soman-related neuropathology.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.toxlet.2020.10.009DOI Listing

Publication Analysis

Top Keywords

cerebral blood
16
blood flow
16
soman exposure
16
brain soman
8
nerve agent
8
neurological damage
8
tissue oxygen
8
pto cerebral
8
exposure
7
soman
6

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!